Rigel Pharmaceuticals
RIGL
#6932
Rank
โ‚ฌ0.59 B
Marketcap
32,35ย โ‚ฌ
Share price
-2.59%
Change (1 day)
80.78%
Change (1 year)

Revenue for Rigel Pharmaceuticals (RIGL)

Revenue in 2026 (TTM): โ‚ฌ0.25 Billion

According to Rigel Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is โ‚ฌ0.26 Billion. In 2025 the company made a revenue of โ‚ฌ0.25 Billion an increase over the revenue in the year 2024 that were of โ‚ฌ0.17 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Rigel Pharmaceuticals from 2000 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) โ‚ฌ0.25 B2.07%
2025 โ‚ฌ0.25 B45.41%
2024 โ‚ฌ0.17 B62.94%
2023 โ‚ฌ0.10 B-5.68%
2022 โ‚ฌ0.11 B-14.93%
2021 โ‚ฌ0.13 B49.22%
2020 โ‚ฌ88.31 M66.86%
2019 โ‚ฌ52.92 M36.03%
2018 โ‚ฌ38.9 M941.09%
2017 โ‚ฌ3.73 M-80.71%
2016 โ‚ฌ19.37 M-26.67%
2015 โ‚ฌ26.42 M289.58%
2014 โ‚ฌ6.78 M31.02%
2013 โ‚ฌ5.17 M204.38%
2012 โ‚ฌ1.7 M-53.5%
2011 โ‚ฌ3.65 M-96.11%
2010 โ‚ฌ93.97 M17852.04%
2009 โ‚ฌ0.52 M
2006 โ‚ฌ25.36 M81.84%
2005 โ‚ฌ13.95 M299.83%
2004 โ‚ฌ3.48 M-60.26%
2003 โ‚ฌ8.78 M-41.86%
2002 โ‚ฌ15.1 M-12.83%
2001 โ‚ฌ17.32 M23.49%
2000 โ‚ฌ14.03 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Amgen
AMGN
โ‚ฌ32.70 B 12,316.31%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚ฌ53.10 B 20,061.99%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sangamo Therapeutics
SGMO
โ‚ฌ30.36 M-88.47%๐Ÿ‡บ๐Ÿ‡ธ USA
ChemoCentryx
CCXI.defunct
โ‚ฌ32.68 M-87.59%๐Ÿ‡บ๐Ÿ‡ธ USA